Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bladder cancer.

H Ozen1

  • 1Department of Urology, Hacettepe University, Ankara, Turkey.

Current Opinion in Oncology
|May 18, 1999
PubMed
Summary
This summary is machine-generated.

Current bladder cancer diagnostics rely on cystoscopy, despite promising non-invasive tests. Accurate prognostic factors, like submucosal invasion depth, are crucial for T1 disease management and survival prediction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new adjacent tool in the management of clinical T1a solid renal masses.

Actas urologicas espanolas·2026
Same author

Neutrophil volume distribution width as a new marker in detecting inflammatory bowel disease activation.

International journal of laboratory hematology·2016
Same author

Successful outcome with second hematopoietic stem cell transplantation in a patient with IL-10R deficiency.

Bone marrow transplantation·2015
Same author

Is routine stenting necessary in pyeloplasty?

Pediatric surgery international·2013
Same author

Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy?

Indian journal of urology : IJU : journal of the Urological Society of India·2010
Same author

Pathological, biochemical and haematological investigations on the protective effect of alpha-lipoic acid in experimental aflatoxin toxicosis in chicks.

British poultry science·2010
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Urology
  • Oncology
  • Diagnostic Medicine

Background:

  • Cystoscopy remains the standard for diagnosing bladder cancer and hematuria, despite its invasive nature.
  • Several non-invasive diagnostic tests, including bladder tumor antigen and nuclear matrix protein 22, are under investigation to reduce cystoscopy frequency.
  • Accurate prognostic factors are needed to predict disease progression, particularly for T1 bladder cancer.

Purpose of the Study:

  • To review current diagnostic methods for bladder cancer and hematuria.
  • To highlight the limitations of existing non-invasive tests and the continued reliance on cystoscopy.
  • To emphasize the importance of prognostic factors, such as invasion depth, for predicting outcomes in T1 bladder cancer.

Main Methods:

  • Review of existing literature on bladder cancer diagnostics and prognostics.

Related Experiment Videos

  • Analysis of the efficacy of various non-invasive tests compared to cystoscopy.
  • Evaluation of prognostic indicators for disease progression and survival.

    • Main Results:

    • While promising, current non-invasive tests have not yet replaced cystoscopy as the standard of care.
    • Depth of submucosal invasion is a critical prognostic factor for survival in T1 bladder cancer.
    • Continent urinary diversions improve quality of life and survival post-cystectomy, potentially due to earlier intervention.

    Conclusions:

    • Cystoscopy remains essential for bladder cancer management, but non-invasive alternatives are evolving.
    • Identifying accurate prognostic factors is vital for tailoring treatment and predicting outcomes in bladder cancer patients.
    • Continent diversions represent a significant advancement in post-cystectomy care, enhancing both survival and quality of life.